MRI guided focused ultrasound (MRgFUS) treatment for uterine fibroids among women with and without abdominal scars. (1st January 2021)

• Record Type: Journal Article
• Authors: Inbar, Yael; Machtinger, Ronit; Barnett-Itzhaki, Zohar; Goldblatt, Avishai; Stoler, Eti; Rabinovici, Jaron
• Is Part Of: International journal of hyperthermia. Volume 38:Number 1(2021)
• Page Start: 1672
• Page End: 1676
• Publication Date: 2021-01-01
• Subjects: MRgFUS -- fibroid -- laparotomy -- non-perfused volume (NPV) -- abdominal scar(s); Thermotherapy -- Periodicals; 615.832
• DOI: 10.1080/02656736.2021.2007302
• Languages: English
• ISSNs: 0265-6736

Abstract

Abstract: Introduction: MRI guided focused ultrasound (MRgFUS) is a noninvasive technique for treating uterine fibroids. The presence of abdominal scars can limit the number of women eligible for the procedure, due to absorbance of beam energy. The goals of this study were to assess the number of women that fit the procedure and to compare outcomes among women with or without abdominal scars. Material and methods: A prospective cohort study of all women that were interested in MRgFUS in a single University-Affiliated Hospital between November 2012 and December 2019. Rates of women that were referred to further screening, fulfilled selection criteria and underwent the procedure were compared between patients with or without abdominal scars. We evaluated the treatment parameters of the two groups and used linear regression model predict non-perfused volume (NPV) at the end of the process. Results: Out of 701 patients, 21.8% were suitable for MRgFUS. Women with scars had significant lower NPV compared with women without scars (60% versus 82.4%, p = 0.021). No serious adverse events were reported in both groups. Linear regression models showed that fibroids' volume, stopping the treatment due to severe pain and the presence of abdominal scars had a statistically significantly negative effect on NPV (betas: −11.51, −6.96, and −6.29, p -values: <0.001, 0.003, and 0.007 respectively), while number of sonication had a statistically significantly positive effect on NPV (beta = 5.98, p = 0.011). Conclusion: Regardless of strict inclusion criteria, MRgFUS treatment is less efficient among women with abdominal scars, although still feasible for those who are interested in noninvasive option.